SENP2 alleviates CCl4-induced liver fibrosis by promoting activated hepatic stellate cell apoptosis and reversion

被引:24
作者
Bu, Fang-Tian [1 ,2 ,3 ]
Chen, Yu [1 ,2 ,3 ]
Yu, Hai-Xia [1 ,2 ,3 ]
Chen, Xin [1 ,2 ,3 ]
Yang, Yang [1 ,2 ,3 ]
Pan, Xue-Yin [1 ,2 ,3 ]
Wang, Qin [1 ,2 ,3 ]
Wu, Yu-Ting [1 ,2 ,3 ]
Huang, Cheng [1 ,2 ,3 ]
Meng, Xiao-Ming [1 ,2 ,3 ]
Li, Jun [1 ,2 ,3 ]
机构
[1] Anhui Med Univ, Sch Pharm, Anhui Inst Innovat Drugs, Key Lab Major Autoimmune Dis, Hefei, Anhui, Peoples R China
[2] Minist Educ, Key Lab Antiinflammatory Immune Med, Hefei, Anhui, Peoples R China
[3] Anhui Med Univ, Inst Liver Dis, Hefei, Anhui, Peoples R China
基金
美国国家科学基金会;
关键词
Liver fibrosis; SENP2; HSC; ss-catenin; HEPATOCELLULAR-CARCINOMA CELL; AXIN-BINDING PROTEIN; BETA-CATENIN; THERAPEUTIC TARGET; SUMO; SUMOYLATION; DESUMOYLATION; EXPRESSION; CANCER; REGRESSION;
D O I
10.1016/j.toxlet.2018.03.010
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
SUMOylation and deSUMOylation, a dynamic process, is proved to be involved in various fibrotic diseases. Here, we found SENP2, one of deSUMOylation protease family member, was decreased in CCl4-induced mice fibrotic liver tissues, primary HSCs and restored after spontaneously recovery. In addition, HSC-T6 cells with TGF-ss 1 treatment resulted in a significant reduction of SENP2. Ectopic expression of SENP2 hindered cells activation and proliferation induced by TGF-ss 1 while knockdown of SENP2 showed an opposite effect. Importantly, SENP2 promoted apoptosis of HSC-T6 cells activated by TGF-ss 1. Furthermore, restoration of SENP2 was observed in inactivated HSCs after adipogenic differentiation mixture (MDI) treatment. Inadequate SENP2 inhibited the reversion of HSC-T6 cells, featured as aberrant expressions of a-SMA and col1a1, two markers of liver fibrosis. It has been reported SENP2 was a suppressant regulator of Wnt/ss-catenin signal pathway. Similarly, we found SENP2 has a negative effect on ss-catenin as well as its downstream genes C-myc and CyclinD1 in liver fibrosis. Collectively, our data indicated SENP2 may be involved in HSCs apoptosis and reversion in liver fibrosis.
引用
收藏
页码:86 / 98
页数:13
相关论文
共 43 条
[1]   Divergent signaling via SUMO modification: potential for CFTR modulation [J].
Ahner, Annette ;
Gong, Xiaoyan ;
Frizzell, Raymond A. .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2016, 310 (03) :C175-C180
[2]  
[Anonymous], MOL IMMUNOL, V80, P58
[3]  
Cai S. P., 2016, TOXICOL LETT, V289, P86
[4]   PTP1B confers liver fibrosis by regulating the activation of hepatic stellate cells [J].
Chen, Pei-Jie ;
Cai, Shuang-Peng ;
Yang, Yang ;
Li, Wan-Xia ;
Huang, Cheng ;
Meng, Xiao-Ming ;
Li, Jun .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2016, 292 :8-18
[5]   Role of desumoylation in the development of prostate cancer [J].
Cheng, Jinke ;
Bawa, Tasneem ;
Lee, Peng ;
Gong, Limin ;
Yeh, Edward T. H. .
NEOPLASIA, 2006, 8 (08) :667-676
[6]   SUMO-Specific Protease 2 Is Essential for Modulating p53-Mdm2 in Development of Trophoblast Stem Cell Niches and Lineages [J].
Chiu, Shang-Yi ;
Asai, Naoya ;
Costantini, Frank ;
Hsu, Wei .
PLOS BIOLOGY, 2008, 6 (12) :2801-2816
[7]   Control of Adipogenesis by the SUMO-Specific Protease SENP2 [J].
Chung, Sung Soo ;
Ahn, Byung Yong ;
Kim, Min ;
Choi, Hye Hun ;
Park, Ho Seon ;
Kang, Shinae ;
Park, Sang Gyu ;
Kim, Young-Bum ;
Cho, Young Min ;
Lee, Hong Kyu ;
Chung, Chin Ha ;
Park, Kyong Soo .
MOLECULAR AND CELLULAR BIOLOGY, 2010, 30 (09) :2135-2146
[8]   SENP1 and SENP2 affect spatial and temporal control of sumoylation in mitosis [J].
Cubenas-Potts, Caelin ;
Goeres, Jacqueline D. ;
Matunis, Michael J. .
MOLECULAR BIOLOGY OF THE CELL, 2013, 24 (22) :3483-3495
[9]   SENP1 promotes proliferation of clear cell renal cell carcinoma through activation of glycolysis [J].
Dong, Baijun ;
Gao, Yujing ;
Kang, Xunlei ;
Gao, Hongchang ;
Zhang, Jin ;
Guo, Hua ;
You, Mingjian J. ;
Xue, Wei ;
Cheng, Jinke ;
Huang, Yiran .
ONCOTARGET, 2016, 7 (49) :80435-80449
[10]   Downregulation of UBC9 promotes apoptosis of activated human LX-2 hepatic stellate cells by suppressing the canonical NF-κB signaling pathway [J].
Fang, Sufen ;
Yuan, Jinhua ;
Shi, Qing ;
Xu, Tiantian ;
Fu, Yao ;
Wu, Zheng ;
Guo, Wuhua .
PLOS ONE, 2017, 12 (03)